Impact Factor
3.51
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.94
908 total citations
h5-index
29
h5 depth signal
Cited share
76.7%
243 of 317
Total citations
908
Citation footprint
Metric signal
2.95
External metric anchor
Self-citation
11.6%
105 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,518
United Kingdom
81
Canada
78
Switzerland
20
France
13
Citing Fields of Research
Patient Care
478
Medical Ethics
398
Healthcare Policy
348
Diabetes
196
Oncology
140
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,901
Articles tracked across the journal lifetime
Indexed publication set
317
243 cited publications
Last 12 months
153
12.8 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
United States
1,518 citing publications
Leading citing field
Patient Care
478 citing publications
Latest tracked publication
1 October 2026
10 recent records available
Coverage & Indexing History
v20n3, Mar. 2014-
v20n3, Mar. 2014-
Active Coverage
Research Focus & Classification
Indexed Subjects
Diabetes
Patient Care
Medical Ethics
Healthcare Policy
Hematology
Psychiatry
Issuing & Sponsoring Bodies
issuing body
Academy of Managed Care Pharmacy
Broad Categories
Pharmacy
Medical Ethics
Patient Care
Diabetes
Psychiatry
Hematology
Musculoskeletal Disorders
MeSH Descriptors
Drug Industry
Managed Care Programs
Pharmaceutical Services
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.18553/jmcp.2026.32.10-a.s1
Open DOI
AMCP Format for Formulary Submissions 6.0
02
DOI 10.18553/jmcp.2026.32.10-b.s1
Open DOI
AMCP Market Insights: Managed care approaches to ESR1 -mutated advanced breast cancer
A mutation in the estrogen receptor alpha gene (ESR1m) following first-line treatment with endocrine therapy in hormone receptor–positive metastatic breast cancer occurs in nearly half of patients.... Plain language summaryMany patients ...
03
DOI 10.18553/jmcp.2026.32.10-c.s3
Open DOI
Expanding the definition of unmet medical need: Findings from a multistakeholder workshop
Unmet medical need (UMN) is frequently referenced in health policy and health care decision-making, including the Centers for Medicare & Medicaid Services' (CMS) Drug Price Negotiation Program (DPNP). However, the concept of UMN is often...
04
DOI 10.18553/jmcp.2026.32.10-c.s2
Open DOI
Characterizing and prioritizing unmet medical needs: Findings from a patient and family caregiver workshop
Defining and measuring unmet medical needs (UMN) from all health care stakeholders is essential for optimizing health care resource allocation decisions and guiding research and development priorities to address them. To understand UMN e...
05
DOI 10.18553/jmcp.2026.32.10-c.s1
Open DOI
Complementary perspectives on unmet medical need domains
06
DOI 10.18553/jmcp.2026.32.10.1319
Open DOI
Payers should cover COVID-19 vaccines for all ages and risk groups with no patient cost sharing
The COVID-19 vaccine saved millions of lives during the pandemic. Clinical trials at the time of authorization and approval showed remarkable effectiveness. However, the effectiveness of the COVID-... Plain language summaryThe effectiven...
07
DOI 10.18553/jmcp.2026.32.10.1313
Open DOI
Vaccines for COVID-19: Effectiveness and value
08
09
10
Bibliographical & Catalog Notes
Also issued online.